HUP9801337A2 - Peptides with growth promotion properties - Google Patents

Peptides with growth promotion properties

Info

Publication number
HUP9801337A2
HUP9801337A2 HU9801337A HUP9801337A HUP9801337A2 HU P9801337 A2 HUP9801337 A2 HU P9801337A2 HU 9801337 A HU9801337 A HU 9801337A HU P9801337 A HUP9801337 A HU P9801337A HU P9801337 A2 HUP9801337 A2 HU P9801337A2
Authority
HU
Hungary
Prior art keywords
xaa
peptides
sequence
leű
pst
Prior art date
Application number
HU9801337A
Other languages
Hungarian (hu)
Inventor
Brian Lee Buckwalter
Hong-Ming Shieh
Bosco Shang Wang
Original Assignee
American Cyanamid Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Company filed Critical American Cyanamid Company
Publication of HUP9801337A2 publication Critical patent/HUP9801337A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány jól meghatárőzőtt másődlagős szerkezettel rendelkező,előnyösen helikális kőnfőrmációjú peptidekre vőnatkőzik, amelyek asertés szőmatőtrőpin (pST) megfelelő régióját űtánőzzák, és főkőzzák apST aktivitását, és elősegítik a melegvérű állatők növekedését. Ezek apeptidek a pST-vel vetélkednek a PS-7.6 jelű mőnőklőnális antitesthezvaló kötődésért. Ezek a peptidek egy 1. azőnősítási számú Xaa-Xaa-Leű-Xaa-Xaa-Ile-Xaa-Xaa-Xaa-Leű-Xaa-Xaa-Val-Xaa- Xaa szekvenciávalrendelkeznek, ahől a szekvencia a pST természetes szekvenciájátólkülönbözik, valamint őlyan szekvenciákkal rendelkeznek, amelyekben azeszenciális aminősavak helyzete hárőm aminősavval el van tőlva, amicsaknem egy teljes menetet jelent a helixen, ezek a peptidek 18.azőnősítási számmal jelzett Xaa-Xaa-Xaa-Xaa-Xaa-Leű-Xaa-Xaa-Xaa-Ile-Xaa-Xaa-Leű-Xaa- Xaa-Xaa-Val szekvenciával rendelkeznek, és aszekvenciájűk a pST természetes szekvenciájától különbözik. ŕThe invention is based on peptides with a well-defined secondary structure, preferably with a helical conformation, which mimic the corresponding region of asteresis tissue tropin (pST) and stimulate the activity of apST and promote the growth of warm-blooded animals. These peptides compete with pST for binding to the PS-7.6 human clonal antibody. These peptides have a sequence number 1 Xaa-Xaa-Leű-Xaa-Xaa-Ile-Xaa-Xaa-Xaa-Leű-Xaa-Xaa-Val-Xaa-Xaa, from which the sequence differs from the natural sequence of pST, as well as sequences in which the positions of the essential amino acids are separated by three amino acids, meaning at least one complete turn on the helix, these peptides are Xaa-Xaa-Xaa-Xaa-Xaa-Leű-Xaa-Xaa-Xaa-Ile-Xaa- They have the sequence Xaa-Leű-Xaa-Xaa-Xaa-Val and have a sequence different from the natural sequence of pST. ŕ

HU9801337A 1995-03-31 1996-03-15 Peptides with growth promotion properties HUP9801337A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41523995A 1995-03-31 1995-03-31

Publications (1)

Publication Number Publication Date
HUP9801337A2 true HUP9801337A2 (en) 1998-08-28

Family

ID=23644898

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801337A HUP9801337A2 (en) 1995-03-31 1996-03-15 Peptides with growth promotion properties

Country Status (10)

Country Link
EP (1) EP0819137A1 (en)
JP (1) JPH11502844A (en)
KR (1) KR19980703438A (en)
AU (1) AU5422596A (en)
BG (1) BG101927A (en)
CA (1) CA2216755A1 (en)
HU (1) HUP9801337A2 (en)
MX (1) MX9707433A (en)
PL (1) PL322585A1 (en)
WO (1) WO1996030405A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699466B1 (en) * 1999-08-05 2004-03-02 Research Corporation Technologies, Inc. IL-16 antagonist peptides and DNA encoding the peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338836A (en) * 1992-07-29 1994-08-16 American Cyanamid Company Biologically active porcine somatotropin polypeptides and methods of using the same

Also Published As

Publication number Publication date
JPH11502844A (en) 1999-03-09
BG101927A (en) 1998-09-30
WO1996030405A1 (en) 1996-10-03
EP0819137A1 (en) 1998-01-21
PL322585A1 (en) 1998-02-02
CA2216755A1 (en) 1996-10-03
MX9707433A (en) 1997-12-31
KR19980703438A (en) 1998-11-05
AU5422596A (en) 1996-10-16

Similar Documents

Publication Publication Date Title
Gimenez-Gallego et al. Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies
DE69431060D1 (en) CLONED GLUTAMIC ACID DECARBOXYLASE
DE69631544D1 (en) Obesity protein (ob) to increase lean body mass
DE69435075D1 (en) , THE SIGNAL SEPENSE PEPTIDES OF THE ENDOPLASMATIC RETICULUM AND AT LEAST ONE OTHER PEPTIDE, THEIR USE IN VACCINES AND THE TREATMENT OF DISEASES
GEP20146050B (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
EP1090039A4 (en) Peptide composition as immunogen for the treatment of allergy
DE60119145D1 (en) AN ANTIGEN AND AN ADJUVANS PEPTIDE CONTAINING VACCINE COMPOSITION
DE69737787D1 (en) CYCLICAL SOMATOSTATIN ANALOGUE WITH A MAIN CHAIN WITH A TENSIED CONFORMATION
DE59007517D1 (en) NEW PROTEINS WITH TNF-INHIBITING EFFECT AND THEIR PRODUCTION.
DE3750342D1 (en) Human gamma interferon-specific receptor protein, antibodies against this protein, methods for producing this protein and antibody and compositions containing this protein and antibody.
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
NL300830I1 (en) Protein Q, a recombinant chimeric protein, consisting of five antigenic fragments of four different Leishmania infantum (zymodeme Mon-1) proteins
EP0825996A4 (en) Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
DE69736276D1 (en) HUMAN DNASE RESISTANT AGAINST ACTININHIBITORS
ATE258933T1 (en) TRANSITION STATE ANALOGUES OF COCAINE, THEIR USE IN PRODUCING CATALTIC ANTIBODIES TO COCAINE AND USE OF THE SAME IN DIAGNOSIS AND THERAPY
HUP9801337A2 (en) Peptides with growth promotion properties
ES2145061T3 (en) DIAGNOSIS AND THERAPY BASED ON PEPTIDES FOR THE TREATMENT OF ESPONDILOARTROPATIAS.
BG105682A (en) Bone stimulating factor
NO20052525D0 (en) Splice variant of human pituitary growth hormone
UA66749C2 (en) Actin-resistant variants of human dnase i, isolated nucleic acid, a method for treatment of patients suffering from pulmonary diseases
PT914417E (en) DNASE II HUMANA
EP0832109A4 (en) Fibroblast growth factor homologous factor-2 and methods of use
DE602004019141D1 (en) ISOLEUCYL-VALYL-THREONYL-ASPARAGINYL-THREONYL-THREONIN (IVTNTT) CONTAINING BIODEGRADABLE PEPTIDES
WO1997006258A3 (en) CDNA sequence, amino-acid sequence, derived from the CDNA sequence, of the precursor protein of human GCAP-II/uroguanyline, and amino-acid sequence of the fragment circulating in human blood
MX9706429A (en) HUMAN DNase I VARIANTS.